References
Onen F (2006) Familial Mediterranean fever. Rheumatol Int 26:489–496
Milhavet F, Cuisset L, Hoffman HM et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808. http://fmf.igh.cnrs.fr/ISSAID/infevers/
El-Garf A, Salah S, Iskander I et al (2009) MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatol Int 30:1293–1298
Ozalkaya E, Mir S, Sozeri B et al (2010) Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey. Rheumatol Int. doi:10.1007/s00296-010-1383-8
Olgun A, Akman S, Kurt I et al (2005) MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 25:255–259
Ureten K, Gonulalan G, Akbal E et al (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915
Inal A, Yilmaz M, Kendirli SG et al (2009) The clinical and genetical features of 124 children with familial Mediterranean fever: experience of a single tertiary center. Rheumatol Int 29:1279–1285
Tchernitchko D, Moutereau S, Legendre M et al (2005) MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum 52:3603–3605
Ben-Chetrit E, Lerer I, Malamud E et al (2000) The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat 15:385–386
Booth DR, Lachmann HJ, Gillmore JD et al (2001) Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. Q J Med 94:527–531
Tchernitchko D, Legendre M, Cazeneuve C et al (2003) The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 22:339–340
Fragouli E, Eliopoulos E, Petraki E et al (2008) Familial Mediterranean fever in Crete: a genetic and structural biological approach in a population of ‘intermediate risk’. Clin Genet 73:152–159
Giaglis S, Papadopoulos V, Kambas K et al (2007) MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 71:458–467
Konstantopoulos K, Kanta A, Lilakos K et al (2005) Familial Mediterranean fever and E148Q pyrin gene mutation in Greece. Int J Hematol 81:26–28
Stoffman N, Magal N, Shohat T et al (2000) Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 8:307–310
Aldea A, Calafell F, Arostegui JI et al (2004) The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination “hot-spot” at the MEFV locus. Hum Mutat 23:399
Topaloglu R, Ozaltin F, Yilmaz E et al (2005) E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis 64:750–752
Touitou I (2001) The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 9:473–483
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cornelius, N., Duno, M. Molecular evaluation of 458 patients referred with a clinical diagnosis of familial Mediterranean fever in Scandinavia. Rheumatol Int 31, 1531–1533 (2011). https://doi.org/10.1007/s00296-010-1604-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1604-1